Skip to main content

Day: July 25, 2024

Groupe Casino: TotalEnergies and Casino renew their partnership for supplying over 1,000 service stations in France

Press release25 July 2024 TotalEnergies and Casino renew their partnership for supplying over 1,000 service stations in France Casino Group and TotalEnergies have announced the renewal of their strategic partnership for supplying more than 1,000 service stations in France. The new agreement, consolidating a partnership of over 20 years between the two companies, will come into force on 1 October 2024 for a duration of five years1. The partnership includes:A nationwide presence: Casino will continue to supply food products and other essential items to more than 1,000 TotalEnergies service stations, nearly 140 of which are located on motorways. A wide range of services: Casino will supply the TotalEnergies service station network in three ways: as a supplier of food products, as a supplier of Casino products and through “Casino Shop” or...

Continue reading

More than 1.5 Million Higher Education Students in the U.S. Now Rely on Quadient Smart Lockers for Package Delivery

Parcel Pending by Quadient Automated Lockers at Valencia College.Parcel Pending by Quadient automated lockers at Valencia College.Parcel Pending by Quadient automated lockers are now installed at more than 250 higher education institutions across the countryParis Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today it has reached a new milestone of installed smart lockers totaling more than 250 colleges and universities across the United States. Across the campuses, more than 1.5 million students per year are served by the automated lockers. Higher education institutions using the Parcel Pending by Quadient automated locker platform range from large universities with tens of thousands of students to smaller colleges with hundreds. Institutions include...

Continue reading

Air France-KLM Half Year Results

xxSECOND QUARTER 2024July 25, 2024Operating result of €513 million with operating margin at 6.5% impacted by unit cost and higher fuel priceGroup capacity increased by 4.1% compared to last year with load factor at 88% Group revenues at €7.9bn, up 4.3% compared to last year Unit cost at +1.7% compared to 2023 Operating result at €513m, with operating margin at 6.5%, Olympic Games impact €40m Half-Year Recurring adjusted operating free cash flow positive at €134m Cash at hand at €9.6bn and Net debt/EBITDA ratio of 1.6xCommenting on the results, Mr. Benjamin Smith, Group CEO, said: “The second quarter of 2024 confirmed an increasingly challenging environment for aviation, with rising fuel prices and a continued pressure on costs. In this context, KLM and Transavia delivered a stable yet sluggish performance, while Air France...

Continue reading

With Important Product-Led Transition Year Underway, Stellantis Delivers €5.6 Billion Net Profit, €8.5 Billion AOI and 10% AOI Margin in the First Half of 2024

    With Important Product-Led Transition Year Underway, Stellantis Delivers €5.6 Billion Net Profit, €8.5 Billion AOI(1) and 10% AOI Margin(2) in the First Half of 2024Net revenues of €85.0 billion, down 14% compared to H1 2023, primarily due to the decline in volume and mix Net profit of €5.6 billion, down 48% compared to H1 2023, primarily due to lower volume and mix, headwinds from foreign exchange and restructuring costs Adjusted operating income(1) of €8.5 billion, down €5.7 billion compared to H1 2023, primarily due to decreases in North America AOI margin(2) of 10%, reflecting direct materials, workforce and logistics cost reductions which helped to mitigate the revenue decline Management taking decisive actions to address operational challenges, including North American share and inventory performance Industrial free cash flows(3)...

Continue reading

Ipsen delivers strong results in the first half of 2024, progresses on launches and upgrades its full-year guidance

PARIS, FRANCE, 25 July 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the first half of 2024. Business highlightsU.S. regulatory approvals and launches of Onivyde® (irinotecan) in first-line pancreatic cancer and Iqirvo® (elafibranor) in second-line primary biliary cholangitis, respectively In-licensing of tovorafenib​ outside the U.S.: an attractive addition to our Oncology pipeline Multiple early-stage external-innovation transactions across Oncology and NeuroscienceFinancial highlightsTotal-sales growth of 9.5% at CER1, or 8.0% as reported, driven by the performances of Cabometyx® (cabozantinib) and Dysport® (abobotulinumtoxinA), as well as contributions from Bylvay® (odevixibat) and OnivydeCore operating margin of 32.4%, a decline...

Continue reading

Arcadis Q2 and Half Year 2024 Results: Continued growth and improved operating margin as 2024-2026 strategy implementation commenced

PRESS RELEASE Arcadis Second Quarter and Half Year Results 2024Continued growth and improved operating margin as 2024-2026 strategy implementation commenced SECOND QUARTER RESULTSNet revenue of €991 million, solid organic growth of 6.0%1) Strong order intake of €1.1B resulting in organic backlog growth of 5.6% year-on-year Improved operating EBITA margin2) to 11.5% (Q2’23: 9.7%3)) driven by operating leverage and improved project portfolio Free cash flow of €8 million (Q2‘23: €-26M), net working capital % of 12.7% (Q2‘23: 12.2%3))Amsterdam, 25 July 2024 – Arcadis, the world’s leading company delivering data-driven sustainable design, engineering, and consultancy solutions for natural and built assets, sees continued growing client demand across all its business, resulting in net revenue of €991 million, organic growth of 6% and an...

Continue reading

STMicroelectronics Reports 2024 Second Quarter Financial Results

STMicroelectronics Reports 2024 Second Quarter Financial ResultsQ2 net revenues $3.23 billion; gross margin 40.1%; operating margin 11.6%; net income $353 million H1 net revenues $6.70 billion; gross margin 40.9 %; operating margin 13.8%; net income $865 million Business outlook at mid-point: Q3 net revenues of $3.25 billion and gross margin of 38%Geneva, July 25, 2024 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, reported U.S. GAAP financial results for the second quarter ended June 29, 2024. This press release also contains non-U.S. GAAP measures (see Appendix for additional information). ST reported second quarter net revenues of $3.23 billion, gross margin of 40.1%, operating margin of 11.6%, and net income of $353 million or $0.38...

Continue reading

Vidac Pharma publishes results of next-generation drug candidate tests in human and murine tumor models

London (UK), July 25, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces that promising results of its study with VDA-1275 in multiple mouse cancer and human cellular organoid models of solid tumors are now available online, as a preprint submitted to peer review. The study showed that VDA-1275 showed statistically significant efficacy as a monotherapy, as well as synergistic effects in combination with two standard-of-care cancer treatments, and that it moreover induced an immunologic response. The main findings of the study were that VDA-1275:reinstates apoptosis (programmed cell death), halts rapid proliferation of cancer cells, reduces the hyper-glycolytic metabolism...

Continue reading

Huhtamäki Oyj’s Half-yearly Report January 1–June 30, 2024: Continued improvement in operational profitability

HUHTAMÄKI OYJ HALF-YEARLY REPORT 25.7.2024 AT 8.30 EEST Q2 2024 in briefNet sales decreased 1% to EUR 1,038 million (EUR 1,052 million) Comparable net sales growth at Group level was -1% Reported EBIT was EUR 105 million (EUR 55 million); adjusted EBIT was EUR 106 million (EUR 93 million) Reported EPS was EUR 0.62 (EUR 0.24); adjusted EPS was EUR 0.63 (EUR 0.55) The impact of currency movements on the Group’s net sales was EUR -6 million and EUR -1 million on EBITH1 2024 in briefNet sales decreased 3% to EUR 2,041 million (EUR 2,099 million) Comparable net sales growth at Group level was -2% Reported EBIT was EUR 182 million (EUR 142 million); adjusted EBIT was EUR 204 million (EUR 185 million) Reported EPS was EUR 0.97 (EUR 0.72); adjusted EPS was EUR 1.17 (EUR 1.06) The impact of currency movements on the Group’s net sales was...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.